Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
April 29 2024
A new study published in the Journal of the American College of Cardiology provides some mechanistic insight into the benefits of physical activity fo...
Results of a large population-based observational cohort study examining the association between weight loss and diabetes remission were recently published in PLOS Medicine. This Hong Kong-based study included more than 37,000 people recently diagnosed with type 2 diabetes who were followed for a median of 8 years, with a focus on their 1-year weight change after diagnosis and their long-term remission rates.
The authors found that only 6% of people achieved remission (defined as 2 consecutive HbA1c <6.5% and no glucose-lowering medications), but the likelihood of remission was greater with a higher degree of weight loss. For example, there was a more than 3-fold (328%) greater chance of remission with ≥10% weight loss (compared to weight gain), versus only a 34% change when losing between 0-5%. Additionally, approximately 2/3 of people that achieved remission eventually returned to hyperglycemia, again, strongly associated with the degree of weight loss. Remission in this study was associated with a 31% lower all-cause mortality rate.
The authors suggest this large population-based cohort provides important insights, as the controlled conditions in clinical trials may not always accurately reflect real-world dynamics. For example, in a randomized trial, a total diet replacement (as part of an aggressive weight loss strategy) was shown to induce remission in nearly ½ of the participants recently diagnosed with diabetes, compared to only 4% in the control group (an odds ratio of 19.7). Furthermore, in this randomized trial, only 7% of those losing 0-5 kg achieved remission, compared to 86% of those who lost 15kg or more (and none of those who gained weight). These studies both strongly suggest weight loss should be heavily emphasized following a diabetes diagnosis, and that perhaps real-world efforts are not nearly aggressive enough.
Submit this form and you'll receive our latest news and updates.
JAMA Network Open recently published the results of a large cohort study that assessed the influence of sleep duration o...
Learn moreA paper published recently in BMJ Nutrition, Prevention & Health documents remission of type 2 diabetes among patien...
Learn moreThe use of continuous glucose monitoring (CGM) among people with insulin-dependent diabetes has gained wider acceptance,...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment